The lowering of the price target from $30 to $28 by UBS suggests a less optimistic view on Marathon Oil's short-term performance, which could lead to a negative impact on the stock price. The Neutral rating indicates no strong buy or sell recommendation, but the reduced target may influence investor sentiment.